SPECS: Safe Pediatric Euglycemia in Cardiac Surgery

• Status: Completed
• Trial end date: 2014-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Critically ill children, including children undergoing heart surgery, commonly develop elevated blood glucose (also known as "blood sugar") levels during their illness, which can lead to poor health outcomes and an increased risk of death. This study will examine the effectiveness of maintaining normal blood glucose levels at decreasing infections and improving recovery in young children undergoing heart surgery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boston Children's Hospital; Boston Children’s Hospital
• Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Insulin; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Undergoing heart surgery with cardiopulmonary bypass

• Recovering in the Cardiac ICU

Exclusion Criteria:

• Enrolled in another interventional clinical trial with related study outcomes